Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients [Phase 2]
Phase 2 trial update for IdeS in asymptomatic antibody-mediated thrombotic thrombocytopenic purpura (TTP) has been terminated; results poste…
-
CLINICAL_TRIALS withdrawal · 2019-02-19Clinical Trial Update: The Role of Microparticles as a Biomarker
A University of Rochester trial evaluating microparticles as a biomarker for atypical hemolytic uremic syndrome and thrombotic thrombocytope…
-
CLINICAL_TRIALS research · 2019-02-06Clinical Trial Update: The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
This entry provides an update on the UK Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry) sponsored by University College Londo…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
Phase 3 trial comparing Uniplas with Cryosupernatant Plasma in thrombotic thrombocytopenic purpura was terminated.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura [Phase 2]
This update reports the completion of a Phase 2 trial evaluating rituximab for adult acquired idiopathic thrombotic thrombocytopenic purpura…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
A Phase 3 trial evaluating the addition of rituximab to standard therapy for thrombotic thrombocytopenic purpura was terminated, with result…
-
CLINICAL_TRIALS research · 2013-06-19Clinical Trial Update: International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
The international registry and biorepository study for thrombotic microangiopathy, including hemolytic uremic syndrome and thrombotic thromb…
-
CLINICAL_TRIALS withdrawal · 2013-04-17Clinical Trial Update: The Plasma Large-Volume Exchange RCT [Phase 3]
A Phase 3 randomized trial of plasma exchange for thrombotic thrombocytopenic purpura and hemolytic uremic syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-21Clinical Trial Update: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura [Phase 4]
The Phase 4 trial of prophylactic plasma infusion therapy for congenital thrombotic thrombocytopenic purpura has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: ADAMTS13 in Thrombotic Thrombocytopenic Purpura
The clinical trial investigating ADAMTS13 for thrombotic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS withdrawal · 2012-11-15Clinical Trial Update: Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura [Phase 1, Phase 2]
A clinical trial evaluating rituximab in addition to standard care for newly presenting thrombotic thrombocytopenic purpura has been withdra…
-
CLINICAL_TRIALS research · 2011-12-29Clinical Trial Update: Influence of Extracorporeal Circulation During Cardiac Surgery on the Development of Postoperative Thrombotic Thrombocytopenic Purpura (TTP)
A clinical trial update examining whether extracorporeal circulation during cardiac surgery affects the development of thrombotic thrombocyt…
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Rituximab in Patients With Relapsed or Refractory TTP-HUS [Phase 2]
Phase 2 trial evaluating rituximab in patients with relapsed or refractory thrombotic thrombocytopenic purpura and hemolytic uremic syndrome…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy [Phase 2]
A Phase 2 clinical trial evaluating ARC1779 for thrombotic microangiopathy was terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders [Phase 2]
Phase 2 clinical trial update for ARC1779 injection in patients with von Willebrand factor-related platelet function disorders; the study st…